Bullish Case: TNC has rebounded +8.2% off 90-day lows, mean reversion favors continued recovery, and call volume ran 71% above puts. A cool IV 'belly' near 75–85 strikes suggests dealers don't price near-term collapse; if margins stabilize and Q4 guidance firms, a re-rate toward the low-80s with IV compression is plausible.

Bearish Case: Helium's forecast is -1.9% and its density function puts dominant probability mass at $45–70, below spot $74.58 — a distributional bearish tilt the market PDF (peak at $70) partially shares. Backwardated term structure and 100–400% IVs in deep-put wings show tail risk is actively priced. Margin pressure commentary (Seeking Alpha, Oct 18) and stale 5-year returns (-11.4%) cap upside.

Potential Outcomes:

1. ~30%: Range $70–80 into Dec 18 expiry; IV belly compresses, skew flattens (falsifiable: 75P IV <30 by Dec).
2. ~28%: Drift lower -8..-15% toward $65–68; Helium density mass at 65–70 realizes; put IVs stay bid.
3. ~20%: Mild recovery +10..15% above $82 on margin/cost-cut news; call skew unwinds.
4. ~15%: Tail shock -20..-35% (earnings/order/legal); left-wing IVs (~403% at 35P) spike further.
5. ~7%: Strategic pop +25% (M&A/asset sale); 85–95 call IVs reprice fast.

November 10, 2026